Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Nova Leap Health Corp. NVLPF

Full chart Compare
Set alert

Price alert · NVLPF

All alert types
0.35 USD 0.00 (+0.00%)

At closeNov 4, 2026, 4:00 PM EST

0.3164 Day range 0.3164
0.1981 52-week range 0.44
YTD
+66.67%
1 year
+62.79%

Financial health

Altman Z-Score

4.44 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

A-4 / 5 overall

  • DCF 4
  • Return on Equity 3
  • Return on Assets 4
  • Debt / Equity 3
  • P/E 3
  • P/B 4

Valuation

P/E -95.5×
FY 2016: -4.5×FY 2017: -4.8×FY 2018: -10.1×FY 2019: -18.3×FY 2020: 25.6×FY 2021: 19.8×FY 2022: -18.7×FY 2023: -13.6×FY 2024: 12.5×FY 2025: -95.5×
FY 2016 5y median -13.6× FY 2025
P/S 0.6×
FY 2016: 54.9×FY 2017: 3.9×FY 2018: 0.9×FY 2019: 1.1×FY 2020: 2.0×FY 2021: 1.6×FY 2022: 0.6×FY 2023: 0.5×FY 2024: 0.7×FY 2025: 0.6×
FY 2016 5y median 0.6× FY 2025
P/B 1.0×
FY 2016: 15.1×FY 2017: 2.3×FY 2018: 1.4×FY 2019: 2.7×FY 2020: 3.4×FY 2021: 1.9×FY 2022: 0.8×FY 2023: 0.8×FY 2024: 0.9×FY 2025: 1.0×
FY 2016 5y median 0.9× FY 2025
P/FCF 13.0×
FY 2016: -6.6×FY 2017: -6.5×FY 2018: -6.2×FY 2019: 32.2×FY 2020: 11.3×FY 2021: 15.9×FY 2022: 16.5×FY 2023: 6.7×FY 2024: 12.6×FY 2025: 13.0×
FY 2016 5y median 13.0× FY 2025
EV/EBITDA 10.0×
FY 2016: -4.4×FY 2017: -5.0×FY 2018: -45.6×FY 2019: 182×FY 2020: 33.1×FY 2021: 10.5×FY 2022: 43.7×FY 2023: -44.2×FY 2024: 12.7×FY 2025: 10.0×
FY 2016 5y median 10.5× FY 2025
EV/Sales 0.6×
FY 2016: 55.7×FY 2017: 4.3×FY 2018: 1.3×FY 2019: 1.3×FY 2020: 2.1×FY 2021: 1.8×FY 2022: 0.7×FY 2023: 0.6×FY 2024: 0.7×FY 2025: 0.6×
FY 2016 5y median 0.7× FY 2025
FCF Yield 7.7%
FY 2016: -15.2%FY 2017: -15.3%FY 2018: -16.2%FY 2019: 3.1%FY 2020: 8.9%FY 2021: 6.3%FY 2022: 6.1%FY 2023: 14.8%FY 2024: 7.9%FY 2025: 7.7%
FY 2016 5y median 7.7% FY 2025

Profitability

Gross Margin 37.0%
FY 2016: 38.6%FY 2017: 34.5%FY 2018: 32.0%FY 2019: 33.6%FY 2020: 33.9%FY 2021: 33.9%FY 2022: 35.4%FY 2023: 37.3%FY 2024: 38.4%FY 2025: 37.0%
FY 2016 5y median 37.0% FY 2025
Operating Margin 3.5%
FY 2016: -1288.4%FY 2017: -85.6%FY 2018: 7.4%FY 2019: -0.6%FY 2020: -2.3%FY 2021: -5.8%FY 2022: -3.8%FY 2023: 1.8%FY 2024: 3.4%FY 2025: 3.5%
FY 2016 5y median 1.8% FY 2025
Net Margin -0.6%
FY 2016: -1224.1%FY 2017: -80.4%FY 2018: -9.3%FY 2019: -6.1%FY 2020: 7.3%FY 2021: 8.3%FY 2022: -3.0%FY 2023: -4.0%FY 2024: 5.4%FY 2025: -0.6%
FY 2016 5y median -0.6% FY 2025
ROE -1.0%
FY 2016: -336.7%FY 2017: -46.8%FY 2018: -14.2%FY 2019: -14.9%FY 2020: 12.8%FY 2021: 9.5%FY 2022: -4.5%FY 2023: -5.8%FY 2024: 7.6%FY 2025: -1.0%
FY 2016 5y median -1.0% FY 2025
ROIC 5.1%
FY 2016: -150.6%FY 2017: -35.3%FY 2018: 6.2%FY 2019: -0.9%FY 2020: -2.4%FY 2021: -3.5%FY 2022: -3.2%FY 2023: 1.8%FY 2024: 3.2%FY 2025: 5.1%
FY 2016 5y median 1.8% FY 2025
ROA -0.8%
FY 2016: -125.0%FY 2017: -29.2%FY 2018: -7.7%FY 2019: -7.5%FY 2020: 7.2%FY 2021: 6.6%FY 2022: -3.5%FY 2023: -5.0%FY 2024: 6.2%FY 2025: -0.8%
FY 2016 5y median -0.8% FY 2025

Growth (YoY)

Revenue 24.3%
FY 2016: 0.0%FY 2017: 2550.2%FY 2018: 877.7%FY 2019: 68.0%FY 2020: -0.5%FY 2021: 22.9%FY 2022: 32.5%FY 2023: -7.2%FY 2024: -1.6%FY 2025: 24.3%
FY 2016 FY 2025
Operating Income 30.3%
FY 2016: 0.0%FY 2017: -76.1%FY 2018: 184.2%FY 2019: -114.8%FY 2020: -251.0%FY 2021: -210.9%FY 2022: 13.7%FY 2023: 143.3%FY 2024: 87.7%FY 2025: 30.3%
FY 2016 FY 2025
EPS (diluted) -113.9%
FY 2016: 0.0%FY 2017: 7.0%FY 2018: 52.1%FY 2019: 12.6%FY 2020: 215.0%FY 2021: 13.1%FY 2022: -145.8%FY 2023: -18.4%FY 2024: 229.5%FY 2025: -113.9%
FY 2016 FY 2025
Free Cash Flow 3.8%
FY 2016: 0.0%FY 2017: -88.6%FY 2018: -149.6%FY 2019: 138.1%FY 2020: 402.3%FY 2021: -27.5%FY 2022: -56.4%FY 2023: 124.0%FY 2024: -35.9%FY 2025: 3.8%
FY 2016 FY 2025

Financial Health

Current Ratio 1.0×
FY 2016: 2.6×FY 2017: 0.4×FY 2018: 0.6×FY 2019: 0.7×FY 2020: 1.0×FY 2021: 1.0×FY 2022: 1.0×FY 2023: 1.6×FY 2024: 1.1×FY 2025: 1.0×
FY 2016 5y median 1.0× FY 2025
Quick Ratio 1.0×
FY 2016: 2.6×FY 2017: 0.4×FY 2018: 0.6×FY 2019: 0.7×FY 2020: 1.0×FY 2021: 1.0×FY 2022: 1.0×FY 2023: 1.6×FY 2024: 1.1×FY 2025: 1.0×
FY 2016 5y median 1.0× FY 2025
Debt / Equity 0.2×
FY 2016: 1.2×FY 2017: 0.3×FY 2018: 0.7×FY 2019: 0.8×FY 2020: 0.6×FY 2021: 0.3×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 0.7×
FY 2016: -0.1×FY 2017: -0.4×FY 2018: -11.7×FY 2019: 31.8×FY 2020: 2.8×FY 2021: 1.2×FY 2022: 6.4×FY 2023: -1.5×FY 2024: 0.8×FY 2025: 0.7×
FY 2016 5y median 0.8× FY 2025
Interest Coverage 3.2×
FY 2016: -160×FY 2017: -41.5×FY 2018: 2.4×FY 2019: -0.2×FY 2020: -0.9×FY 2021: -3.1×FY 2022: -3.9×FY 2023: 3.2×FY 2024: 8.1×FY 2025: 3.2×
FY 2016 5y median 3.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31